rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Michael A. Ross

Director

Company insider

Files Form 4 as: Director, 20/20 Biolabs.

In numbers

Trades disclosed
4
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
19 Feb 2026
Last trade
19 Feb 2026
Last filed
23 Feb 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
AIDX 20/20 BiolabsDirector · Professional Services · last 19 Feb 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
19 Feb 2026filed 23 Feb 2026AIDX 20/20 BiolabsProfessional ServicesSEC FORM 4 Code C—31 at $0.00filing
19 Feb 2026filed 23 Feb 2026AIDX 20/20 Biolabsoption or derivative · Professional ServicesSEC FORM 4 Code C—31filing
19 Feb 2026filed 23 Feb 2026AIDX 20/20 Biolabsoption or derivative · Professional ServicesSEC FORM 4 Code C—31filing
19 Feb 2026filed 23 Feb 2026AIDX 20/20 BiolabsProfessional ServicesSEC FORM 4 Code C—31 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Alan B. BergmanChief Financial Officer · Chief Financial Officer at 20/20 Biolabs, filing Form 4 there in the last year
Jiming ZhouChief Operating Officer · Chief Operating Officer at 20/20 Biolabs, filing Form 4 there in the last year
Jonathan M. CohenChief Executive Officer · Chief Executive Officer at 20/20 Biolabs, filing Form 4 there in the last year
Richard M. CohenDirector · Director at 20/20 Biolabs, filing Form 4 there in the last year
John G. ComptonDirector · Director at 20/20 Biolabs, filing Form 4 there in the last year